In HR-positive breast cancers, despite the fact that FOXP3+ TIL was significantly higher in DCIS-INV than in pure DCIS, the other TIL subsets seemed to increase in number at a late stage of DCIS progression, or seemed unlikely to be associated with in situ to invasive transition. Here, FOXP3 is linked to ductal breast carcinoma in situ.